Introduction
============

Drug discovery and clinical analysis are areas in which efficient, accurate, cost-effective, and convenient analytical methods are needed. A balance between the different criteria is best reached by systematic parameter optimization for the specific detection scheme of choice and, if possible, automation.[@b1-ijn-10-859] Accomplishments in automation of electroanalysis schemes include computer-controlled microfluidic devices with voltammetric detection in flow-through electrochemical chambers,[@b2-ijn-10-859] non-manually operated electrode microarrays,[@b3-ijn-10-859] microtiter plates with multiplexed three-electrode systems on vial bottoms,[@b4-ijn-10-859] and electrochemical analyzers with robotic sampling and pipetting.[@b5-ijn-10-859],[@b6-ijn-10-859] Our own recent contribution to automatic electroanalysis is timed voltammetry, with a three-electrode assembly that moves sequentially between microtiter plate wells for nonmanual analyte determinations at user-specified points. With graphite pencil "leads" used as working electrodes (PL-WEs), this setup was capable of accurate robotic differential pulse voltammetry (DPV) of vitamin C,[@b7-ijn-10-859] automated amperometric total antioxidant capacity measurements,[@b8-ijn-10-859] and robotic trace lead and cadmium stripping voltammetry.[@b9-ijn-10-859] Motivated by pharmaceutical and clinical interest in drug assays, our next aim was to develop easily handled antibiotic analysis by microtiter plate-based voltammetry. Two antibiotics, norfloxacin (NFX) and ciprofloxacin (CFX), served as model analytes in evaluating this approach. Voltammetric antibiotic quantification is, however, often limited by poor redox conversion of this group of analytes at bare carbon or noble metal electrodes, which badly affects the onset of faradaic current signals and thus compromises sensitivity and accuracy. This can be improved by coating the sensor with materials that facilitate electron transfer for drug electroxidation or reduction.[@b10-ijn-10-859]--[@b16-ijn-10-859] Based on earlier reports of success with carbon nanotube (CNT)-assisted NFX[@b17-ijn-10-859],[@b18-ijn-10-859], CFX[@b19-ijn-10-859],[@b20-ijn-10-859] and other analyte[@b22-ijn-10-859]--[@b24-ijn-10-859] voltammetry, electrophoretic CNT deposition[@b21-ijn-10-859] was chosen to modify the PL-WEs in the three-electrode assembly of a robotic workstation for NFX and CFX voltammetry. Through parameter optimization for WE modification, CNT layers were obtained that enabled stable and accurate NFX/CFX detection during voltammetric microtiter plate runs.

We report the details of the sensor testing by voltammetry, results of robotic voltammetric drug calibrations in preloaded microtiter plates, and NFX/CFX quantification by robotic drug voltammetry in model, dissolved tablet, and, for NFX, human serum samples with added analyte. In contrast to previously described options for automated electroanalysis, the practice described in this study does not need complicated microfluidics or complex electrode structures. Its application in pharmacoanalytics for nonmanual antibiotic sample evaluation is thus practical, provided that the target molecules are electroactive and hence suitable for electrochemical detection.

Material and methods
====================

Chemicals and materials
-----------------------

Analytical grade NFX and CFX powders were from Sigma-Aldrich GmbH (Munich, Germany) while their tablet formulations came from QUALIMED Co, Ltd (Bangkok, Thailand) (NFX, type Norfar^®^, 400 mg/tablet) and MILLIMED Co, Ltd (Bangkok Thailand) (CFX, type Cobay^®^, 500 mg/tablet). Stock solutions of 1 mM drug were prepared by dissolving their powders in 0.01 M HCl. NFX was measured in acetate buffer (0.1 M in 0.1 M KCl, pH 4.5), while phosphate buffers (0.1 M in 0.1 M KCl, pH 4.0) were used for CFX. The electrolyte for cyclic voltammetry (CV) and DPV electrode tests was 1 mM K~3~\[Fe(CN)~6~\] in 0.1 M KCl.NaNO~3~ (anhydrous, 99%) and N~2~ gas (99.99%, Linde Thailand, Thailand) were used to make and condition the electrolyte for the voltammetric evaluation of WE capacitances. If no specific source and quality is stated, chemicals were analytical grade and obtained via Italmar (Thailand) Co, Ltd (Bangkok, Thailand). Drug stock and test solutions and buffers used ultrapure deionized water. Human serum was made from the whole blood of a healthy volunteer following a standard isolation protocol.

Common heat-shrinking tubes, as used in electrical engineering for the isolation of wirings and joints, and 0.5-mm-diameter pencil leads (Pentel^®^ HB, Pentel Co, Ltd, Bangkok, Thailand) from a local stationery shop were used for the fabrication of PL-WEs. The process of polymer tube sealing left \~2 mm of the pencil lead exposed at the bottom end, which brought \~3 mm^2^ into use as electroactive area. A 1-mm-diameter Ag wire (Goodfellow, Cambridge, UK) became the applied pseudo-Ag/AgCl reference electrode (RE) via 10-minute application of a DC voltage of 10 V vs a Pt wire in 1 M HCl/3 M KCl electrolyte, with consequent formation of a well-adhering layer of AgCl. A coiled 0.5-mm-diameter Pt wire (Goodfellow) served as counterelectrode (CE), with an immersed area of about 500 mm^2^. For thin-film surface modification of PL-WEs, aqueous suspensions of purified single-walled CNTs, with 1.0--3.0 at.% carboxylic acid entities (P3-SWNT; Carbon Solutions, Inc, Riverside, CA, USA), were used.

Instrumentation
---------------

The PL-WEs for NFX and CFX trials in the robotic voltammetry mode were obtained by inserting 3-cm-long pieces of the thin graphite sticks into heat-shrinking tubes of marginally larger diameter. It was ensured that 4 mm of the pencil leads projected at the top to act as contact point to the WE potentiostat cable and 2 mm came out at the bottom to serve as the sensor. A hot air stream from a laboratory heat gun was then used to trigger the desired temperature-induced tube shrinking, which, with no involvement of an inert composite sealant material as, for instance, epoxy- or silicon-based resins, reproducibly sealed the conductive microfilament into a tightly gripping polymeric cover. A home-made WE/CE/RE holder was used to form a movable three-electrode assembly, which was small enough to enter the microtiter plate vials via a micropositioning system control without the risk of damage ([Figure 1](#f1-ijn-10-859){ref-type="fig"}).

The potentiostat was a PalmSens^®^ device (PalmSens BV, Utrecht, the Netherlands), and a set of computer-controlled micropositioners (Owis GmbH, Staufen im Breisgau, Germany) enabled vertical (z) electrode and horizontal (x/y) microtiter plate movements. The hardware and software of the workstation moved the electrode assembly in a user-defined sequence from well to well and made voltammetric recordings during halts of preset lengths. Manual voltammetric sensor tests used conventional beaker-type electrochemical cells and the PalmSens^®^ potentiostat. A function generator (Agilent Technologies, Inc, Santa Clara, CA, USA) served as power supply for CNT electrodeposition on PL-WEs, and a scanning electron microscope (eSEM Dual Beam™ Quanta 3D FEG, FEI, Hillsboro, OR, USA) was used for inspection of the electrodes.

CNT modification of PL-WEs
--------------------------

Before use, PL-WEs were cleaned by dipping in 4 M nitric acid for 1 minute, then rinsed with deionized water, and air-dried. The electrolyte for electrical field-induced CNT deposition onto PL-WE surfaces was a 20 mg/mL suspension of the carboxylated graphitic filaments in water, ultrasonicated for 30 minutes. As illustrated in [Figure 2A](#f2-ijn-10-859){ref-type="fig"}, CNT film formation on PL-WE surfaces was accomplished in a small beaker-type two-electrode cell by 10-minute application of a constant potential of +1 V, against a platinum wire CE.

Results and discussion
======================

CNT sedimentation and defect-free thin film formation on the PL-WE substrates were first examined by SEM. In low-magnification SEM micrographs, the ultrathin superficial nanomaterial covering was not resolved and CNT-modified and bare PL-WEs appeared virtually identical (insets of [Figure 2B](#f2-ijn-10-859){ref-type="fig"}). At higher magnification, however, the dense nanoporous CNT network on the outside of treated PL-WEs became clearly evident ([Figure 2B](#f2-ijn-10-859){ref-type="fig"}). Electrodeposited CNT layers were uniformly and firmly stacked on the surface of the PL-WE with no sign of cracking or delamination. The visible nanoporosity of the films suggested an increased electroactive surface area compared with the unmodified surfaces.

The results of subsequent manual voltammetric assessment of the intrinsic surface properties of bare and CNT-modified PL-WEs are shown in [Figures 3](#f3-ijn-10-859){ref-type="fig"} and [4](#f4-ijn-10-859){ref-type="fig"}. Cyclic potential scans with the electrodes in redox-mediator-free, 99.99% pure, N~2~-purged electrolyte produced quasi-rectangular voltammograms, typical of a purely capacitive electrode response ([Figure 3A and C](#f3-ijn-10-859){ref-type="fig"}). As expected, the anodic and cathodic charging currents *I* were directly proportional to scan speed *v* (graphs not shown). Plots of Δ*I* (ie, the difference between the two currents extracted from the voltammograms at the same potential) against *v* were also linear (*R*^2^\>0.999, [Figure 3B](#f3-ijn-10-859){ref-type="fig"} and D).

Measurement of Δ*I* as a function of *v* allowed calculation of the individual electrode double-layer capacitance *C* from the formula *C* = Δ*I*/(2*v*). The average values for otherwise identical PL-WEs, with and without CNT, were 111±7 μF (n=3) and 67±5 μF (n=3), respectively. Since the capacitance of an electrode is directly proportional to its effective area, the \~1.7-fold larger *C*-value for the CNT-modified PL-WE confirmed the observation from SEM inspection that the porosity of the thin-layer films of the carbon filaments created an electrode structure with enlarged contact area for the electrolyte.

The increase in sensitivity produced by the CNT coating is shown in [Figure 4](#f4-ijn-10-859){ref-type="fig"}. Here we compare the standard ferricyanide DPV at bare and CNT-modified PL-WEs. In each case, there was a well-defined symmetrical current peak for the reduction of ferricyanide at the graphitic surface; however, while the peak potentials were identical, their amplitudes differed significantly, with the CNT modification producing \~2.3-fold higher cathodic redox current. Thus, the increase in surface area shown by the SEM and CV inspections of the interfacial nanotube network in [Figures 2](#f2-ijn-10-859){ref-type="fig"} and [3](#f3-ijn-10-859){ref-type="fig"} led to a clear voltammetric signal enhancement. Interestingly, a decrease in the charge transfer resistance *R*~ct~ across the electrode/electrolyte interface has been reported in a number of published studies (eg, in Refs [@b22-ijn-10-859]--[@b24-ijn-10-859]); this effect is another advantage of the CNT electrode covering and, though not specifically studied here, may have contributed to the observed increase in the ferricyanide reduction peak current.

In preliminary manual antibiotic voltammetry trials, DPVs were recorded for NFX and CFX with a bare and a CNT-modified PL-WE. For 100 μM NFX, a representative pair of DPV traces is shown in [Figure 5](#f5-ijn-10-859){ref-type="fig"}. The bare PL-WE produced only a slight deflection for the anodic oxidation of NFX, while electroxidation at the CNT-modified PL-WE resulted in a pronounced peak, suitable for quantitative analysis. Apparently, the nanotube film enhanced the electrochemical oxidation of NFX and (data not shown) also CFX, the second antibiotic studied. Reliably, manual NFX and CFX DPV produced proportional current peaks for concentrations up to 10 μM and 100 μM, respectively. The minimum antibiotic levels producing analyzable current peaks with CNT PL-WEs as detectors were 0.3±0.1 μM (n=7) for NFX and 1.6±0.1 μM (n=7) for CFX. We concluded at this stage that operational analytical voltammetry of the selected antibiotics could be accomplished only with a current-enhancing CNT layer on the surface of the PL-WE. All subsequent robotic trials therefore used thin CNT-modified PL-WEs.

The establishment of robotic antibiotic voltammetry began with tests of the stability of the system's response to the analytes through complete microtiter plate voltammetry trials. As indicated in [Figure 6](#f6-ijn-10-859){ref-type="fig"}, all sample wells in microtiter plate rows 2, 4, and 6 were filled with the antibiotic solution of a concentration within the manually determined linear response range. Use of the electrode assembly for an automated analytical plate run, with sensor cleaning between individual measuring steps, produced 12 antibiotic voltammograms (data not shown). Statistical analysis of all peak currents revealed virtually constant values for both 8 μM NFX (3.71±0.11 μA, n=12) and 50 μM CFX (2.81±0.12 μA, n=12) during the 3-hour (NFX) and 2-hour (CFX) plate runs. This superb signal stability meant that analyte degradation and sensor fouling could be excluded, at least for up to 3 hours of recording.

Calibration curves were acquired automatically with the microtiter plate loadings outlined in [Figure 6](#f6-ijn-10-859){ref-type="fig"}. Typical plate calibration runs began with dipping the PL-WE in HNO~3~ (well A1), followed by dip-cleaning in deionized H~2~O (well A3), and, finally the acquisition of the first voltammogram in buffer alone (well A2). The steps of acid sensor conditioning, water cleaning, and use were repeated throughout the test until all the sample wells had been tested and the resultant DPVs stored. Completion of one full plate run thus navigated the three-electrode assembly in the following sequence through the 24 individual wells: A1, A3, A2, A1, A3, A4, A1, A5, A6, A1, B1, B2, A1, B3, B4, A1, B5, B6, A1, C1, C2, A1, C3, C4, A1, C5, C6, A1, D1, D2, A1, D3, D4, D1, D5, D6. Representative sets of automatically acquired NFX and CFX DPVs and the related standard plots of the extracted voltammetric peak currents against the corresponding analyte concentrations are shown in [Figure 7](#f7-ijn-10-859){ref-type="fig"}. With the parameter set used, linearity of the DPV response, with *R*^2^ values above 0.99, was maintained up to 10 μM and 100 μM for NFX and CFX, respectively. Typical average values for the current sensitivity of CNT PL-WEs against NFX and CFX were 0.421±0.007 μA/μM (NFX, n=3) and 0.070±0.001 μA/μM (CFX, n=3). Also, the minimum detectable NFX and CFX concentrations in robotic voltammetry PL-WEs were equivalent to the measures of the manual analog. It is worth mentioning here that the current peak maxima of NFX and CFX DPVs are in the order of 100 mV distant to each other on the potential scale. This significant anodic peak separation technically would be suitable for simultaneous NFX and CFX determination; however, direct dual detection of the two drugs was not the focus of the current work but may be explored in future application of the methodology.

[Table 1](#t1-ijn-10-859){ref-type="table"} presents the analytical figures of merit of NFX and CFX DPV in the novel robotic mode and measured with CNT-modified PL-WEs, in comparison with equivalent data for manual voltammetric detection of the two analytes with various previously reported CNT-modified and CNT-free electrochemical sensors, which used polished disks of glassy carbon (GC), pyrolytic carbon (PC), carbon paste (CP), and gold (Au) or mercury (Hg) films on carbon or noble metal electrode disks as precursor structures. In automatic operation, the performance of CNT-modified PL-WEs reached in terms of linear range and sensitivity for both analytes about the level of the cited manual procedures. Slightly poorer detection limits and linear ranges probably reflect differences in the sensor's base material, which was common pencil graphite in this study but GC, PC, CP, Au, or Hg in the previous reports. Graphite pencil "leads" contain up to 20% clay as added binder material, and the presence of this nonconducting inorganic ingredient may to a small extent reduce electron charge transfer on the graphitic planes across the PL-WE surfaces. Our experience showed, however, that notwithstanding this effect, the results of robotic NFX/DPV at CNT-modified PL-WEs were satisfactory, provided the target sample levels were within the detectable range. Confirmed was in the automated calibration trials an analytical performance that was as good as possible with the GC/PC/CP/Au/Hg equivalents. And reach of the indispensable signal stability of PL-WEs for the entire time of their use in the robotic electrochemical workstation was evident from robotic 2--3 hours voltammetric microtiter plate runs with, for instance, no significant current decay for the same NFX/CFX levels in all sample plate wells. This was an important new technical accomplishment because PL-WEs in terms of design and ease of fabrication turned out to be most practical for implantation into the movable three-electrode assembly of the robotic electrochemical microtiter plate assay. The potential of the methodology was thus further explored for antibiotic determinations in various test solutions. Buffer solutions of defined NFX and CFX concentrations were screened first, to test the recovery of analyte. Simulations of biological samples were made from pharmaceutical NFX and CFX formulations dissolved in the measuring buffers or from fresh human blood serum spiked with NFX.

Microtiter plate loading for robotic voltammetric antibiotic quantification in the standard addition mode is shown in [Figure 8](#f8-ijn-10-859){ref-type="fig"}. The wells in row 1 contained HNO~3~ (A1) and H~2~O (B1, C1, D1) and all vessels in row 2 contained buffer solution. The wells in the rows 3--6 contained the samples, either untreated or spiked with antibiotic. With this layout, the four samples could be processed in 3-hour (NFX) or 2-hour (CFX) automated runs, without any operator involvement. A representative example of the resulting raw data is shown in [Figure 9A](#f9-ijn-10-859){ref-type="fig"} as a set of four DPVs that were successively acquired during robotic NFX determination in human blood serum. A plot of the peak currents of the presented DPVs against added NFX levels was linear ([Figure 9B](#f9-ijn-10-859){ref-type="fig"}), and the regression line (*R*^2^=0.997) extrapolation to zero current and/or a calculation based on the corresponding line equation (*y*=1.61*x*+3.36) allowed determination of the endogenous NFX level in the original sample. Actually, the final concentration of NFX added to the serum was 2.00 μM, while that measured was 2.09 μM. The recovery, defined here as the ratio of the value obtained from robotic DPV analysis divided by the known value of serum sample supplementation, was thus 103.5%±5.1%. The outcome of all robotic voltammetry NFX and CFX sample measurements, in terms of apparent recoveries, is summarized in [Table 2](#t2-ijn-10-859){ref-type="table"}. Values in the range 97%--104% recovery were consistent with the standard method performance requirements recommended by the Association of Analytical Communities for the range of analyte concentration.[@b35-ijn-10-859] Thus, the quality of the proposed automated electrochemical microtiter plate assay, with CNT-modified PL-WEs, was comparable with traditional manual voltammetric methods for measuring the two chosen antibiotics. The convenience of automation is an additional asset, and use of the proposed methodology for analysis of sample libraries is thus feasible.

Conclusion
==========

A novel microtiter plate-based robotic voltammetric antibiotic assay that uses CNT-modified PL-WEs as tailored sensors for analyte quantification has been developed. For two model antibiotics, NFX and CFX, the automated electroanalysis offered good response stability and a practical linear response range. Near-perfect recoveries during measurements of standard solutions, dissolved pharmaceutical tablets, and spiked human serum samples confirmed the reliability of the methodology. An important factor in achieving this electroanalytical performance was the modification of the working electrode surface with a thin film of CNTs, as only then was reliable electrochemical antibiotic detection possible. Simple automation of the voltammetric analytical procedure microtiter plate stage conferred the additional benefits of manual error exclusion, convenience, and operator time-saving. In summary, this novel analytical approach may be a useful alternative to labor-intensive, manual, multiple-sample antibiotic screening in pharmaceutical work and, considering that antibiotics are ubiquitous pollutants of ground and surface water and soil,[@b36-ijn-10-859],[@b37-ijn-10-859] valuable also for application to large sets of environmental samples in governmental and private control and protection agencies. In relation to the current worldwide fears about the dramatic rise in the number of multidrug-resistant infectious microorganisms[@b38-ijn-10-859] and the related global "apocalyptic" threat of unchecked antibiotic resistance development by bacterial pathogens,[@b39-ijn-10-859] our planned future work will target applications in pharmaceutical and environmental antibiotic studies and also address the utilization of the technique for the pharmacokinetic study of bacterial antibiotic efflux pumps.
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![The device (**A**) for robotic antibiotic electroanalysis in 24-well microtiter plates (**B**).\
**Notes:** The major components are (1) the three-electrode assembly with a pencil lead-WE, a platinum-CE (counterelectrode), and a Ag/AgCl-RE (reference electrode); (2) the microtiter plate platform; (3) the micropositioning stage for vertical movement of the electrode assembly; (4) two micropositioning stages for lateral microtiter plate movement; and (5) (not shown) a potentiostat and a personal computer for system operation and voltammetry.\
**Abbreviations:** CE, counter-electrode; WE, working electrode; RE, reference electrode; WE, working electrode.](ijn-10-859Fig1){#f1-ijn-10-859}

![Modification of pencil lead electrodes with carbon nanotubes.\
**Notes:** (**A**) Schematic of the electrophoretic CNT deposition procedure. At a DC voltage of +1 V for 10 minutes, a well-adhering CNT thin layer is deposited on the PLE, which is then tuned for use as the working electrode for electrochemical drug measurements in the robotic electrochemical workstation. (**B**) High-resolution SEM image of a randomly selected area on the surface of a CNT-modified PLE (16,000×); the bottom left and right insets are low-resolution SEM images of the CNT-modified (60×) and a bare (50×) PLE, respectively. The area of the zoom shown as part (**B**) was located within the white box in the left insert.\
**Abbreviations:** PLE, pencil lead electrode; SEM, scanning electron microscopy; CNT, carbon nanotube.](ijn-10-859Fig2){#f2-ijn-10-859}

![Electrode capacitance determinations for a bare and a CNT-modified PL-WE by cyclic voltammetry in oxygen-free, N~2~-purged, 0.1 M NaNO~3~.\
**Notes:** (**A**) and (**C**) are the original voltammograms as recorded at seven scan rates in between 20 mV/s and 200 mV/s (from inner to outer traces). Plots (**B**) and (**D**) are of the width of the quasi-rectangular CVs at 0.05 V vs Ag/AgCl, against the scan speed. Errors bars in (**B**) and (**D**) represent the standard deviation of three measurements; if not clearly visible, the bars happened to be smaller in width than the markers used for data point presentation.\
**Abbreviations:** CNT, carbon nanotube; CV, cyclic voltammetry; PL-WE, pencil lead working electrode.](ijn-10-859Fig3){#f3-ijn-10-859}

![Ferricyanide differential pulse voltammetry with a bare (green) and a CNT-modified (red) pencil lead electrode.\
**Notes:** The concentration of \[Fe(CN)~6~\]^3−^ was 1 mM in 0.1 M KCl and the parameters for DPV acquisition were as follows: pulse amplitude 25 mV, pulse width 25 ms and scan speed 20 mV/s.\
**Abbreviations:** CNT, carbon nanotube; DPV, differential pulse voltammetry.](ijn-10-859Fig4){#f4-ijn-10-859}

![DPV of NFX with a bare (black) and a CNT-modified (red) pencil lead working electrode.\
**Notes:** NFX concentration was 10 μM in 0.1 M acetate buffer (pH 4.5)/0.1 M KCl. Parameters for DPV acquisition were as follows: pulse height 25 mV, pulse width 25 ms and scan speed 20 mV/s, with 300 seconds allowed at 0.4 V vs Ag/AgCl before actual DPV initiation.\
**Abbreviations:** CNT, carbon nanotube; DPV, differential pulse voltammetry; NFX, norfloxacin.](ijn-10-859Fig5){#f5-ijn-10-859}

![The microtiter plate well loading for robotic voltammetric NFX and CFX stability tests and calibration trials, with CNT-modified pencil lead working electrodes.\
**Notes:** For stability tests, all wells in rows 2, 4, and 6 (including A2) contained sample solution (8 μM for NFX and 50 μM for CFX). For calibration trials, drug levels were between 0 (well A2) and 100 μM (well D6) in 0.1 M acetate (pH 4.5)/0.1 M KCl (NFX) or 0.1 M phosphate (pH 4)/0.1 M KCl (CFX) buffers. Parameters for DPV acquisition in the microtiter plate wells were as follows: pulse height and width 25 mV and 25 ms; scan range and speed 0.4--1.2 V vs RE and 20 mV/s; waiting time before DPV scan initiation 300 seconds (NFX) and 180 seconds (CFX) at 0.4 V vs RE; 25°C. Analytical runs started in well A1 (electrode pretreatment) and finished in well D6 (last sample solution).\
**Abbreviations:** CFX, ciprofloxacin; CNT, carbon nanotube; DPV, differential pulse voltammetry; NFX, norfloxacin; RE, reference electrode.](ijn-10-859Fig6){#f6-ijn-10-859}

![NFX (**A**) and CFX (**B**) differential pulse voltammograms from robotic calibration measurement in a 24-well microtiter plate.\
**Notes:** The insets are plots of the peak currents as a function of antibiotic concentration. Electrolyte for in-well DPV was a 0.1 M acetate (pH 4.5)/0.1 M KCl buffer for NFX and a 0.1 M phosphate (pH 4)/0.1 M KCl buffer for CFX. DPV parameters were as follows: pulse height and width 25 mV and 25 ms; scan range and speed 0.4--1.2 V vs. RE and 20 mV/s; waiting time before DPV scan initiation 300 s (NFX) and 180 s (CFX) at 0.4 V vs RE; 25°C. Errors bars in the insets of (**A**) and (**B**) represent the standard deviation of three measurements; however, the bars are smaller in width than the markers used for data point presentation and thus do not appear clearly. The peak potentials for the highest concentrations of NFX and CFX are 0.96 and 1.06 V vs Ag/AgCl, respectively.\
**Abbreviations:** CFX, ciprofloxacin; NFX, norfloxacin; DPV, differential pulse voltammetry; RE, reference electrode.](ijn-10-859Fig7){#f7-ijn-10-859}

![Microtiter plate loading as used for robotic voltammetric NFX and CFX quantification trials with CNT-modified pencil lead working electrodes and the standard addition method.\
**Notes:** Electrolyte for in-well DPV was a 0.1 M acetate (pH 4.5)/0.1 M KCl buffer for NFX and a 0.1 M phosphate (pH 4)/0.1 M KCl buffer for CFX. DPV parameters were as follows: pulse height and width 25 mV and 25 ms; scan range and speed 0.4--1.2 V vs. RE and 20 mV/s; waiting time before DPV scan initiation 300 s (NFX) and 180 s (CFX) at 0.4 V vs RE; 25°C. Analytical runs started in well A1 (electrode pretreatment) and ended in well D6 (last sample solution).\
**Abbreviations:** CFX, ciprofloxacin; CNT, carbon nanotube; DPV, differential pulse voltammetry; NFX, norfloxacin; SA, standard addition; RE, reference electrode.](ijn-10-859Fig8){#f8-ijn-10-859}

![Robotic voltammetric quantification of NFX in spiked human serum samples by the standard addition method.\
**Notes:** A set of four DPVs for buffer alone, a serum sample with 2 mM NFX supplementation, and the solution with three additions of NFX, all acquired in an automated run through a loaded microtiter plate (**A**). Standard addition curve and linear regression plot (**B**). Electrolyte for in-well NFX-DPV was a 0.1 M acetate (pH 4.5)/0.1 M KCl buffer. DPV parameters were as follows: pulse height and width 25 mV and 25 ms; scan range and speed 0.4--1.2 V vs. RE and 20 mV/s; waiting time before DPV scan initiation 300 s at 0.4 V vs RE; 25°C. Errors bars in (**B**) represent the standard deviation of three measurements; however, the error bar for the 4 μM data point is smaller in width than the marker used for data point presentation and thus does not appear clearly. The green arrow points toward the x-axis interception, which represents the actual analyte concentration of the inspected sample.\
**Abbreviations:** DPVs, differential pulse voltammograms; NFX, norfloxacin; RE, reference electrode.](ijn-10-859Fig9){#f9-ijn-10-859}

###### 

Comparison of analytically relevant figures of merit of different electrochemical strategies for the quantitative determination of NFX and CFX

  Study                             Detection scheme   Electrode type         DL (nM)     LR (μM)         S (μA/μM)
  --------------------------------- ------------------ ---------------------- ----------- --------------- -----------
  NFX/CNT                                                                                                 
   This work                        DPV                SWCNT/PL               300         1--100          0.422
   Agrawal et al[@b25-ijn-10-859]   SWV                MWCNT/PG               41          1--1,000        0.072
   Devaraj et al[@b17-ijn-10-859]   DPV                CuO-MWCNTs/GC          321         1--48           0.028
   Huang et al[@b18-ijn-10-859]     CV                 MWCNT-Nafion/GC        50          0.1--100        0.241
  NFX/others                                                                                              
   Wang et al[@b26-ijn-10-859]      AMP                NP-MIP/Au              0.1         0.001--1,000    0.324
   Goyal et al[@b27-ijn-10-859]     SWV                EPPG                   283         0.3--30         0.906
   Huang et al[@b18-ijn-10-859]     LSV                PMRE/GC                100         1--100          0.280
   Reddy et al[@b28-ijn-10-859]     DPV                CPE                    390         0.44--34        0.55
  DPV                               CD/CP              50                     0.054--34   2.43            
   Ni et al[@b29-ijn-10-859]        LSSV               Hg                     25          0.06--6         7.5
   Ghoneim et al[@b30-ijn-10-859]   Ad-SWV             GC                     2.5         1.5--15         0.442
  CFX/CNT                                                                                                 
   This work                        DPV                SWCNT/PL               1,600       2--100          0.070
   Ensafi et al[@b31-ijn-10-859]    CV                 MgFe~2~O~4~-MWCNT/GC   10          0.1--1,000      0.185
   Fotouhi et al[@b19-ijn-10-859]   CV                 MWCNT/GC               6           40--1,000       0.076
   Ensafi et al[@b20-ijn-10-859]    CV                 MWCNT/GC               900         3.0--1,200      0.157
  CFX/others                                                                                              
   Zhang et al[@b32-ijn-10-859]     CV                 PAR/EGR/GC             10          0.04--120       0.246
   Zhang and Wei[@b33-ijn-10-859]   DPV                SDBS-CP                20          0.08--5         3.0
   Ionescu et al[@b34-ijn-10-859]   EIS                Anti-CFX/Au            0.032       30×l0^−06^--3   --
   Ni et al[@b29-ijn-10-859]        LSSV               Hg                     33          0.1--9          6.2

**Abbreviations:** Ad-SWV, adsorptive square wave voltammetry; AMP, amperometry; Anti-CFX, CFX-specific antibody; Au, gold; CFX, ciprofloxacin; CP, carbon paste; CV, cyclic voltammetry; DL, detection limit; DPV, differential pulse voltammetry; EIS, electrochemical impedance spectroscopy; EPPG, edge plane pyrographite; GC, glassy carbon; Hg, mercury; LR, linear range; LSSV, linear sweep stripping voltammetry; LSV, linear sweep voltammetry; MWCNT, multiwall carbon nanotube; NF-MIP, norfloxacin molecular imprinted polymer; NFX, norfloxacin; PAR/EGR, poly(alizarin red)/electrodeposited graphene; PG, pyrolytic graphite; PL, pencil lead; PMRE, poly(methyl red); S, sensitivity; SDBS, sodium dodecyl benzene sulfonate; SWCNT, single wall carbon nanotube; SWV, square wave voltammetry.

###### 

Recoveries from robotic microtiter plate voltammetry of NFX and CFX in supplemented prototype, dissolved tablet, and spiked serum samples

  Sample                          Concentration   Recovery rate (%)   
  ------------------------------- --------------- ------------------- ------------
  NFX model sample, μM (n=16)     2.0             2.01±0.07           100.3±3.6
  NOFAR 400 mg/tablet, mg (n=8)   --              392.40±1.47         98.1±0.4
  NFX in serum sample, μM (n=4)   2.0             2.07±0.02           103.51±5.1
  CFX model sample, μM (n=8) --   10.0            9.92±0.39           99.2±2.5
  COBAY 500 mg/tablet, mg (n=8)   --              488.60±5.52         97.7±3.3

**Abbreviations:** CFX, ciprofloxacin; NFX, norfloxacin.
